Rein Therapeutics, Inc. (RNTX) stock
RNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.36−0.00 (-0.31%)
Close on Nov 18, 2026Market cap $30.65MP/E –Yield 0.00%
Rein Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Rein Therapeutics's market cap was $51.97M on Nov 11, 2026, against $39.47M a year earlier. Over the last 5 years it ranged from $5.31M to $89.10M, with a median of $32.03M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $51.97M | +78.2% |
| 2025 | Dec 31, 2025 | $29.16M | -41.5% |
| 2024 | Dec 31, 2024 | $49.83M | +259.9% |
| 2023 | Dec 29, 2023 | $13.84M | +28.6% |
| 2022 | Dec 30, 2022 | $10.76M | -78.9% |
| 2021 | Dec 31, 2021 | $50.98M | +22.9% |
| 2020 | Dec 31, 2020 | $41.47M | +160.2% |
| 2019 | Dec 31, 2019 | $15.94M | +28.7% |
| 2018 | Dec 31, 2018 | $12.38M | -92.0% |
| 2017 | Dec 29, 2017 | $155.14M | – |
See a number that looks wrong?